Raj K. Puri - 23 May 2025 Form 4 Insider Report for IOVANCE BIOTHERAPEUTICS, INC. (IOVA)

Role: Chief Regulatory Officer
Signature: /s/ Raj K. Puri
Issuer symbol: IOVA
Transactions as of: 23 May 2025
Net transactions value: +$9,743
Form type: 4
Filing time: 27 May 2025, 16:06:43 UTC
Previous filing: 18 Mar 2025
Next filing: 04 Jun 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Puri Raj K.	Chief Regulatory Officer	C/O IOVANCE BIOTHERAPEUTICS, INC., 825 INDUSTRIAL ROAD, SUITE 100, SAN CARLOS	/s/ Raj K. Puri	27 May 2025	0002046483

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IOVA	Common Stock	Purchase	$9,743	+5,600	+2.8%	$1.74	206,852	23 May 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares were acquired in the open market during a permitted trading window in accordance with the Issuer's Insider Trading Policy. A copy of the Insider Trading Policy is filed as Exhibit 19.1 to the Issuer's Annual Report on Form 10-K for the year ended December 31, 2024.